Research.Patient.info
Transthyretin Amyloidosis With Cardiomyopathy research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE3
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
This study is testing a new medicine, nucresiran, for people with a heart condition called transthyretin amyloidosis cardiomyopathy. Doctors want to see if it can improve health, reduce heart-related problems, and make patients feel better compared to a dummy medicine.
United States · Argentina · Australia - recruiting
Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
This study is looking at the long-term safety of a medicine called eplontersen for people with a condition called transthyretin amyloidosis (ATTR). It also specifically checks how the medicine affects those who have had a liver transplant or have severe liver problems.
United States · Canada · China